Skip to main navigation Skip to search Skip to main content

BAX activation is initiated at a novel interaction site

  • Evripidis Gavathiotis
  • , Motoshi Suzuki
  • , Marguerite L. Davis
  • , Kenneth Pitter
  • , Gregory H. Bird
  • , Samuel G. Katz
  • , Ho Chou Tu
  • , Hyungjin Kim
  • , Emily H.Y. Cheng
  • , Nico Tjandra
  • , Loren D. Walensky
  • Dana-Farber Cancer Institute
  • Boston Children's Hospital
  • Harvard University
  • National Institutes of Health
  • Washington University St. Louis

Research output: Contribution to journalArticlepeer-review

626 Scopus citations

Abstract

BAX is a pro-apoptotic protein of the BCL-2 family that is stationed in the cytosol until activated by a diversity of stress stimuli to induce cell death. Anti-apoptotic proteins such as BCL-2 counteract BAX-mediated cell death. Although an interaction site that confers survival functionality has been defined for anti-apoptotic proteins, an activation site has not been identified for BAX, rendering its explicit trigger mechanism unknown. We previously developed stabilized α-helix of BCL-2 domains (SAHBs) that directly initiate BAX-mediated mitochondrial apoptosis. Here we demonstrate by NMR analysis that BIM SAHB binds BAX at an interaction site that is distinct from the canonical binding groove characterized for anti-apoptotic proteins. The specificity of the human BIM-SAHB-BAX interaction is highlighted by point mutagenesis that disrupts functional activity, confirming that BAX activation is initiated at this novel structural location. Thus, we have now defined a BAX interaction site for direct activation, establishing a new target for therapeutic modulation of apoptosis.

Original languageEnglish
Pages (from-to)1076-1081
Number of pages6
JournalNature
Volume455
Issue number7216
DOIs
StatePublished - Oct 23 2008

Fingerprint

Dive into the research topics of 'BAX activation is initiated at a novel interaction site'. Together they form a unique fingerprint.

Cite this